Denali Therapeutics Gehälter & Vergütung
Tech
Denali Therapeutics is a US-based biopharmaceutical company that develops therapeutic candidates for neurodegenerative diseases. Its product candidates include LRRK2 inhibitor, DNL310, DNL343, AR443820/DNL788, and SAR443122/DNL758. The company has collaboration agreements with various pharmaceutical companies and research institutions. It was formerly known as SPR Pharma Inc. and was incorporated in 2013.
Hauptsitz:South San Francisco, United States
Gegründet:2015
Mitarbeiter:201-1,000
Typ:public
Geschätzter Umsatz:$100M-$250M
4
Gehaltsangaben
$150K
Ø Gesamtvergütung
$125K
Median Gesamtvergütung
USD
Währung
Statistiken in USD (umgerechnet). Wähle ein Land für genaue lokale Zahlen.
Hauptsitz